Works matching IS 13419625 AND DT 2025 AND VI 30 AND IP 2

Results: 25

Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 397, doi. 10.1007/s10147-024-02673-2

By:

Outani, Hidetatsu;
Ikegami, Masachika;
Imura, Yoshinori;
Nakai, Sho;
Takami, Haruna;
Kotani, Yuki;
Inoue, Akitomo;
Okada, Seiji

Publication type:

Article

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for locally advanced uterine cervical cancer, and durvalumab and olaparib for advanced or recurrent endometrial cancer in Japan.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 170, doi. 10.1007/s10147-024-02679-w

By:

Matsumura, Noriomi;
Mandai, Masaki

Publication type:

Article

Comprehensive epidemiology of melanoma at all sites: insights from Japan's National Cancer Registry, 2016–2017.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 194, doi. 10.1007/s10147-024-02675-0

By:

Ogata, Dai;
Namikawa, Kenjiro;
Nakano, Eiji;
Fujimori, Maiko;
Uchitomi, Yosuke;
Higashi, Takahiro;
Satake, Tomoyuki;
Morizane, Chigusa;
Yamazaki, Naoya;
Kawai, Akira

Publication type:

Article

Prognostic significance of lymph node metastasis of soft tissue sarcoma of the extremities. National cancer institute experience.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 407, doi. 10.1007/s10147-024-02674-1

By:

Shalaby, Mohamed;
Allam, Rasha M.;
Elkordy, Mohamed A.;
Taher, Mohammad

Publication type:

Article

Treatment-related skin reactions in enfortumab vedotin as a surrogate marker of survival and treatment response.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 267, doi. 10.1007/s10147-024-02672-3

By:

Nagayama, Jun;
Inoue, Satoshi;
Sai, Hiroki;
Hayakawa, Akira;
Yuguchi, Yuri;
Suzuki, Tomohide;
Matsui, Hirotaka;
Yuba, Takuma;
Morishita, Koya;
Akamatsu, Shusuke

Publication type:

Article

Celebrating 30 years of IJCO: shaping the future of clinical oncology.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 169, doi. 10.1007/s10147-025-02704-6

By:

Mandai, Masaki

Publication type:

Article

Analysis of lung cancer incidence, mortality trends, and smoking rates in Japan:1975–2022 with insights on the impact of COVID-19.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 199, doi. 10.1007/s10147-025-02695-4

By:

Yamamoto, Hiroki;
Shirasawa, Masayuki;
Naoki, Katsuhiko

Publication type:

Article

Transforming cancer screening: the potential of multi-cancer early detection (MCED) technologies.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 180, doi. 10.1007/s10147-025-02694-5

By:

Imai, Mitsuho;
Nakamura, Yoshiaki;
Yoshino, Takayuki

Publication type:

Article

Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 229, doi. 10.1007/s10147-024-02689-8

By:

Jo, Ami;
Shoji, Tadahiro;
Otsuka, Haruka;
Abe, Marina;
Tatsuki, Shunsuke;
Chiba, Yohei;
Sato, Sho;
Takatori, Eriko;
Kaido, Yoshitaka;
Nagasawa, Takayuki;
Kagabu, Masahiro;
Baba, Tsukasa

Publication type:

Article

A prospective study comparing highly qualified Molecular Tumor Boards with AI-powered software as a medical device.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 172, doi. 10.1007/s10147-024-02684-z

By:

Bando, Hideaki;
Naito, Yoichi;
Yamada, Tomoyuki;
Fujisawa, Takao;
Imai, Mitsuho;
Sakamoto, Yasutoshi;
Saigusa, Yusuke;
Yamamoto, Kouji;
Tomioka, Yutaka;
Takeshita, Nobuyoshi;
Sunami, Kuniko;
Futamura, Megumi;
Notake, Chiemi;
Aoki, Satoko;
Okano, Kazunori;
Yoshino, Takayuki

Publication type:

Article

Postoperative adjuvant therapy with molecularly targeted agents for non-small cell lung cancer.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 210, doi. 10.1007/s10147-024-02671-4

By:

Miyoshi, Tomohiro;
Tsuboi, Masahiro

Publication type:

Article

Efficacy of androgen receptor signaling inhibitors in combination with androgen deprivation therapy for castration-sensitive metastatic prostate cancer: a retrospective analysis in a Japanese cohort.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 351, doi. 10.1007/s10147-024-02670-5

By:

Taga, Minekatsu;
Sasaki, Takeshi;
Higashi, Shinichiro;
Kimura, Shoichi;
Sawada, Atsuro;
Tsuchiyama, Katsuki;
Inoue, Takahiro;
Kamoto, Toshiyuki;
Terada, Naoki

Publication type:

Article

Evaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database study.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 298, doi. 10.1007/s10147-024-02669-y

By:

Nakane, Sayuri;
Yuri, Akinori;
Miyano, Yuki;
Yamada, Kana;
Nakatsuji, Erika;
Takei, Nobuki;
Igarashi, Yasuhiro;
Harada, Ryousuke

Publication type:

Article

Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 380, doi. 10.1007/s10147-024-02668-z

By:

Honda, Kazunori;
Kajimoto, Yusuke;
Suzuki, Shiro;
Mori, Masahiko;
Nakao, Kohshiro;
Azuma, Anri;
Shibutani, Takashi;
Nagao, Shoji;
Koyanagi, Takahiro;
Kohara, Izumi;
Tamaki, Shuko;
Yabuki, Midori;
Teng, Lida;
Igarashi, Ataru

Publication type:

Article

The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 371, doi. 10.1007/s10147-024-02667-0

By:

Yunokawa, Mayu;
Abe, Akiko;
Wang, Xiaofei;
Toyohara, Yusuke;
Nimura, Ryo;
Komoto, Takayuki;
Misaka, Satoki;
Yoshimitsu, Teruyuki;
Ikki, Ai;
Kamata, Mayumi;
Nishino, Shogo;
Kanno, Motoko;
Fusegi, Atsushi;
Netsu, Sachiho;
Aoki, Yoichi;
Omi, Makiko;
Tanigawa, Terumi;
Okamoto, Sanshiro;
Nomura, Hidetaka;
Kanao, Hiroyuki

Publication type:

Article

The clinical significance of signal regulatory protein alpha expression in the immune environment of gastric cancer.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 330, doi. 10.1007/s10147-024-02666-1

By:

Tanaka, Yasushi;
Hu, Qingjiang;
Kawazoe, Tetsuro;
Tajiri, Hirotada;
Nakanishi, Ryota;
Zaitsu, Yoko;
Nakashima, Yuichiro;
Ota, Mitsuhiko;
Oki, Eiji;
Oda, Yoshinao;
Yoshizumi, Tomoharu

Publication type:

Article

Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 277, doi. 10.1007/s10147-024-02664-3

By:

Jiang, Wenjie;
Zhang, Fan;
Tang, Zhen;
Xu, Shuonan;
Zhang, Yukun;
Liu, Lina;
Zhong, Daixing;
Liu, Yingxiang

Publication type:

Article

Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 389, doi. 10.1007/s10147-024-02662-5

By:

Goto, Hideki;
Kumode, Takahiro;
Mishima, Yuko;
Kataoka, Keisuke;
Ogawa, Yoshiaki;
Kanemura, Nobuhiro;
Shimada, Kazuyuki;
Uchida, Toshiki;
Kuroe, Yukano;
Kawasaki, Atsuko;
Sato, Jotaro;
Teshima, Takanori

Publication type:

Article

Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 320, doi. 10.1007/s10147-024-02661-6

By:

Nishikawa, Kazuhiro;
Koizumi, Wasaburo;
Tsuburaya, Akira;
Suzuki, Motoko;
Morita, Satoshi;
Fujitani, Kazumasa;
Akamaru, Yusuke;
Shimada, Ken;
Hosaka, Hisashi;
Nishimura, Ken;
Yoshikawa, Takaki;
Tsujinaka, Toshimasa;
Sakamoto, Junichi

Publication type:

Article

Effects of aging on complications following robot-assisted radical prostatectomy.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 340, doi. 10.1007/s10147-024-02660-7

By:

Koterazawa, Shigeki;
Kubota, Masashi;
Sumiyoshi, Takayuki;
Saito, Ryoichi;
Takaoka, Naoto;
Hattori, Yuto;
Shimizu, Yosuke;
Kanno, Toru;
Soda, Takeshi;
Okada, Yoshiyuki;
Tsuchihashi, Kazunari;
Sekine, Yuya;
Negoro, Hiromitsu;
Kurahashi, Ryoma;
Shimatani, Kimihiro;
Sawada, Atsuro;
Akamatsu, Shusuke;
Goto, Takayuki;
Kobayashi, Takashi

Publication type:

Article

Relationship between patient-reported health-related quality of life as measured with the SF-36 or SF-12 and their mortality risk in patients with diverse cancer type: a meta-analysis.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 252, doi. 10.1007/s10147-024-02659-0

By:

Tanaka, Takashi;
Morishita, Shinichiro;
Nakano, Jiro;
Inoue, Junichiro;
Okayama, Taro;
Suzuki, Katsuyoshi;
Osaki, Keiichi;
Fukushima, Takuya

Publication type:

Article

Phase Ib study of the oral PI3Kδ inhibitor linperlisib in patients with advanced solid tumors.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 241, doi. 10.1007/s10147-024-02657-2

By:

Li, Jin;
Xue, Junli;
Liu, Tianshu;
Feng, Yi;
Xu, Nong;
Huang, Jianjin;
Yin, Yongmei;
Zhang, Jun;
Mou, Haibo;
Shentu, Jiangzhong;
Bao, Hanying;
Xu, Zusheng;
Xu, Zuhong

Publication type:

Article

Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 309, doi. 10.1007/s10147-024-02656-3

By:

Zhou, Jinsong;
Liu, Shuang;
Zhang, Juwei;
Zeng, Qiaoyan;
Lin, Zheng;
Fu, Rong;
Lin, Yulan;
Hu, Zhijian

Publication type:

Article

Robotic dual-docking surgery for para-aortic lymphadenectomy in endometrial cancer: a prospective feasibility study.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 358, doi. 10.1007/s10147-024-02635-8

By:

Yanazume, Shintaro;
Kobayashi, Hiroaki;
Ushiwaka, Takashi;
Togami, Shinichi;
Kamio, Masaki

Publication type:

Article

Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements.

Published in:

International Journal of Clinical Oncology, 2025, v. 30, n. 2, p. 215, doi. 10.1007/s10147-023-02459-y

By:

Takenaka, Masaru;
Kuroda, Koji;
Tanaka, Fumihiro

Publication type:

Article